CLIA Kit for Prostate Specific Antigen (PSA)

KLK3; APS; KLK2A1; HK3; KLKB1; Seminin; Prostate Specific Antigen; Kallikrein-Related Peptidase 3; Semenogelase, g-Seminoprotein; P-30 Antigen; Plasma kallikrein

  • CLIA Kit for Prostate Specific Antigen (PSA) Packages (Simulation)
  • CLIA Kit for Prostate Specific Antigen (PSA) Packages (Simulation)
  • CLIA Kit for Prostate Specific Antigen (PSA) Results demonstration
  • SCA151Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Prostate Specific Antigen (PSA)

This assay has high sensitivity and excellent specificity for detection of Prostate Specific Antigen (PSA).
No significant cross-reactivity or interference between Prostate Specific Antigen (PSA) and analogues was observed.

Recovery of the CLIA Kit for Prostate Specific Antigen (PSA)

Matrices listed below were spiked with certain level of recombinant Prostate Specific Antigen (PSA) and the recovery rates were calculated by comparing the measured value to the expected amount of Prostate Specific Antigen (PSA) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 92-101 95
EDTA plasma(n=5) 80-102 91
heparin plasma(n=5) 85-99 93

Precision of the CLIA Kit for Prostate Specific Antigen (PSA)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Prostate Specific Antigen (PSA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Prostate Specific Antigen (PSA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Prostate Specific Antigen (PSA)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Prostate Specific Antigen (PSA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-103% 99-105% 91-99% 79-101%
EDTA plasma(n=5) 83-90% 80-104% 84-99% 92-105%
heparin plasma(n=5) 88-95% 96-103% 78-102% 95-103%

Stability of the CLIA Kit for Prostate Specific Antigen (PSA)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Prostate Specific Antigen (PSA)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Prostate Specific Antigen (PSA)

The microplate provided in this kit has been pre-coated with an antibody specific to Prostate Specific Antigen (PSA). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Prostate Specific Antigen (PSA). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Prostate Specific Antigen (PSA) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
EPA151Hu61 Eukaryotic Prostate Specific Antigen (PSA) Positive Control; Immunogen; SDS-PAGE; WB.
RPA151Hu01 Recombinant Prostate Specific Antigen (PSA) Positive Control; Immunogen; SDS-PAGE; WB.
APA151Hu61 Active Prostate Specific Antigen (PSA) Cell culture; Activity Assays.
CPA151Hu21 OVA Conjugated Prostate Specific Antigen (PSA) Immunogen; SDS-PAGE; WB.
PAA151Hu01 Polyclonal Antibody to Prostate Specific Antigen (PSA) WB; IHC; ICC; IP.
PAA151Hu02 Polyclonal Antibody to Prostate Specific Antigen (PSA) WB; IHC; ICC; IP.
MAA151Hu23 Monoclonal Antibody to Prostate Specific Antigen (PSA) WB; IHC; ICC; IP.
MAA151Hu24 Monoclonal Antibody to Prostate Specific Antigen (PSA) WB
MAA151Hu21 Monoclonal Antibody to Prostate Specific Antigen (PSA) WB; IHC; ICC; IP.
MAA151Hu22 Monoclonal Antibody to Prostate Specific Antigen (PSA) WB; IHC; ICC; IP.
SEA151Hu ELISA Kit for Prostate Specific Antigen (PSA) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA151Hu CLIA Kit for Prostate Specific Antigen (PSA) Chemiluminescent immunoassay for Antigen Detection.
LMA151Hu Multiplex Assay Kit for Prostate Specific Antigen (PSA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA151Hu01 ELISA Kit DIY Materials for Prostate Specific Antigen (PSA) Main materials for "Do It (ELISA Kit) Yourself".
GUESTBOOK